Add BrightSurf on Google Email

World Journal of Gastroenterology


Oral sodium phosphate laxative inducing hyperphosphatemia relates with weight?

A study published in World Journal of Gastroenterology found that oral sodium phosphate (OSP) laxatives can induce hyperphosphatemia in low-risk patients, particularly those with lower weights. The research suggests that preoperative evaluation and adjusting OSP doses according to weight may help prevent this condition.

SourceWorld Journal of Gastroenterology·JournalWorld Journal of Gastroenterology·DateJan 15, 2010

Incidental findings at MRI-enterography

In a study published in World Journal of Gastroenterology, researchers found that MRI-enterography revealed incidental findings outside the small intestine in 25% of patients with suspected or known Crohn's disease. These extra-intestinal manifestations were rare and did not necessarily require additional examinations.

SourceWorld Journal of Gastroenterology·JournalWorld Journal of Gastroenterology·DateJan 14, 2010

Shift working aggravates metabolic syndrome development among middle-aged males

A recent study published in World Journal of Gastroenterology found that shift work significantly increases the development of metabolic syndrome (MetS) among early-middle-aged males with elevated alanine aminotransferase (ALT). The researchers observed that workers with both baseline e-ALT and long-term rotating shift work exposures h...

SourceWorld Journal of Gastroenterology·JournalWorld Journal of Gastroenterology·DateDec 16, 2009

Spontaneous liver rupture in a patient with peliosis hepatis

Peliosis hepatis, a rare pathological entity, can lead to spontaneous liver rupture, a life-threatening condition that necessitates prompt medical intervention. The case report highlights the importance of considering PH in patients with risk factors, emphasizing the need for early diagnosis and treatment to prevent severe complications.

SourceWorld Journal of Gastroenterology·JournalWorld Journal of Gastroenterology·DateDec 8, 2009

Heparanase-specific shRNA: A novel therapeutic strategy in human gastric cancer

Research on heparanase-specific shRNA reveals its potential as a novel therapeutic strategy for human gastric cancer. The study successfully knocked down HPA expression in gastric cancer cells, leading to decreased invasiveness and metastasis. This finding suggests a new approach for treating cancers overexpressing HPA.

SourceWorld Journal of Gastroenterology·JournalWorld Journal of Gastroenterology·DateNov 25, 2009

Can EP4 agonist alleviate gastric lesions?

A research team investigated a highly-selective EP4 agonist for treatment of gastric ulcers in mice. The EP4 agonist reduced acute hemorrhagic damage, promoted mucous epithelial regeneration, and accelerated ulcer healing. In vitro, it protected human gastric mucous cells from indomethacin-induced apoptosis.

SourceWorld Journal of Gastroenterology·JournalWorld Journal of Gastroenterology·DateNov 18, 2009

Is type 2 diabetes mellitus a risk factor for gallbladder, biliary and pancreatic cancer?

A large cohort study found that patients with type 2 diabetes mellitus have a threefold increased risk of pancreatic cancer and a twofold increased risk of gallbladder and extrahepatic biliary cancers compared to non-diabetic controls. This is the first comprehensive assessment of the risk for these cancers in type 2 DM patients.

SourceWorld Journal of Gastroenterology·JournalWorld Journal of Gastroenterology·DateNov 18, 2009

Travel of a mis-swallowed long spoon to the jejunum

A 33-year-old woman accidentally swallowed a 15 cm long spoon while attempting to remove a fish bone from her pharynx. The spoon was found in the lower mid-abdomen on an urgent plain abdominal radiograph and successfully removed during exploratory laparotomy, revealing it had passed into the jejunum after 200 cm of the ligament of Treitz.

SourceWorld Journal of Gastroenterology·JournalWorld Journal of Gastroenterology·DateOct 28, 2009

A new explanation of 'Asian paradox'

Researchers investigated gastric mucosal changes prior to gastric cancer in Indonesian and Japanese patients with H. pylori infection. They found significant differences in the grade and activity of mucosal changes, suggesting a different host response between the two populations.

SourceWorld Journal of Gastroenterology·JournalWorld Journal of Gastroenterology·DateOct 28, 2009

Is short-term Celecoxib intervention a effective method for preventing gastric carcinogenesis?

A new study found that short-term Celecoxib intervention can effectively prevent gastric carcinogenesis in Mongolian gerbils. The research team suggests that COX-2 inhibitors may be used as chemoprevention for people older than 40 years old, especially those with refractory H. pylori infections at high risk of gastric cancer.

SourceWorld Journal of Gastroenterology·JournalWorld Journal of Gastroenterology·DateOct 28, 2009

Long-term treatment with proton pump inhibitor can increase weight

A study published in World Journal of Gastroenterology found that long-term proton pump inhibitor (PPI) treatment can lead to weight gain in patients with gastroesophageal reflux disease (GERD). The research highlights the importance of lifestyle modifications, such as dietary changes and weight management, to mitigate this effect. By ...

SourceWorld Journal of Gastroenterology·JournalWorld Journal of Gastroenterology·DateOct 22, 2009

What's the clonality status and allelotype of focal nodular hyperplasia?

Researchers analyzed 12 focal nodular hyperplasia (FNH) lesions and found polyclonal nature with no loss of heterozygosity in most cases, contrasting with 40% monoclonality in altered hepatocytes. This study provides an approach for differential diagnosis and may lead to further understanding of early human hepatocarcinogenesis.

SourceWorld Journal of Gastroenterology·JournalWorld Journal of Gastroenterology·DateOct 18, 2009

Which is promising as therapeutic targets in patients with biliary tract cancer? EGFR or HER2?

A study of 124 patients with advanced biliary tract cancer found EGFR overexpression in 39.3% of tumors, while HER2 overexpression and gene amplification were present in only 5% of cases. This suggests that targeting EGFR may be a promising therapeutic approach for BTC, while routine testing and targeting of HER2 is not recommended.

SourceWorld Journal of Gastroenterology·JournalWorld Journal of Gastroenterology·DateOct 16, 2009